Skip to main content
. 2013 Aug 6;109(4):909–914. doi: 10.1038/bjc.2013.442

Table 2. Three-month progression-free rate overall and according to histological group.

Population Success Failures Success % 95% CI
All
9
36
20.0
9.6–34.6
TRS
4
10
28.6
8.4–58.1
Non-TRS sarcomas 5 26 16.1 5.5–33.7

Abbreviations: CI=confidence interval; TRS=Translocation-related sarcomas.